Six-monthly CD4 cell monitoring 'unnecessary' for people doing well on HIV therapy
Any reduction in viral load has immunologic benefits for people with HIV who have triple-class treatment failure
Poor CD4 response to HIV treatment increases risk of death from non-AIDS-related illnesses, even for those with higher baseline counts
Low levels of vitamin D associated with poorer long-term CD4 cell gains in women who start HIV treatment late
Denmark: Late HIV diagnosis not a major factor in continued spread of HIV
UNITAID commits US$140 million to bring HIV diagnostic technologies to the ‘point of care’
